Ours Privacy raises $15M to make healthcare marketing measurable again

Why it matters

Ours Privacy turned the founders' inability to measure telehealth marketing safely into a healthcare data platform. The $15M round backs a broader push to replace fragmented marketing stacks with one controlled layer.

Ours Privacy, founded by Jessica Holton, Adam Putterman and Tyler Zey, said on August 19 that it raised a $15M Series A to expand the privacy and marketing infrastructure the trio first built for their own telehealth operation.

Lightbank and Health Velocity Capital led the round. Existing investors Rock Health, Lakehouse, TMV, Switch Ventures, Starfire Ventures and GreyMatter also participated, according to Ours Privacy's funding announcement.

Holton serves as CEO, Putterman as chief revenue officer and Zey as chief technology officer. They launched Ours Privacy as a commercial platform in 2024 after encountering the problem while operating Ours Wellness, a couples-therapy and relationship-health service that handled unusually sensitive information.

The founders' path into healthcare data infrastructure began with a blunt operating decision: remove the conventional marketing stack. Putterman told AdExchanger in 2025 that Ours Wellness initially ran without third-party scripts, advertising pixels, video embeds or even a Google Font because of the data those tools could send outside its systems.

That protected patient information and left the founders unable to see what their acquisition spending produced. Zey built a server-side system that let Ours Wellness control and anonymize data before sending selected information to advertising and analytics platforms. Agency partners began asking for access, turning the internal workaround into a product opportunity.

"We built Ours Privacy because we lived this problem ourselves," Zey said in the announcement.

A privacy tool expands into the whole marketing stack

Ours Privacy collects website and customer data through server-side connections, then filters or de-identifies sensitive fields before sending permitted information to services such as Google Analytics, Google Ads and Meta. Ours Privacy markets the product as a HIPAA-compliant customer data platform and offers signed business associate agreements.

The product has expanded well beyond pixel replacement. Ours Privacy now sells consent management, tag management, analytics, attribution, audience building, A/B testing, personalization, session replay, embedded maps and videos, and an automated web scanner. Ours Privacy also says its infrastructure is hosted in the United States and has obtained SOC 2 Type II compliance.

That product breadth is central to the Series A bet. Healthcare marketing departments have often assembled analytics, consent, experimentation and advertising workflows from separate vendors. Each additional connection creates another place where protected health information can move unexpectedly. Ours Privacy is trying to consolidate those functions inside one controlled data layer, giving healthcare organizations fewer integrations to audit and giving Ours Privacy a larger share of their marketing software budgets.

Ours Privacy says it serves more than 200 healthcare organizations and processes billions of data points each month. Those figures are company-reported. The announcement named Oceans Healthcare as a customer, alongside an otherwise unnamed mix of health systems, medical brands and digital health providers.

Rock Health previously led a 2025 financing connected to Ours Privacy's launch of an integrated consent-management product. The new investor group adds a specialist healthcare software fund in Health Velocity Capital and a generalist technology investor in Lightbank as the founders push further into enterprise healthcare.

Regulation created the opening, with some important limits

The founders launched into a market shaken by federal guidance, enforcement actions and state privacy laws. The Department of Health and Human Services says tracking technologies on authenticated patient pages generally have access to protected health information. Vendors handling that information may need business associate agreements, and HHS specifically identifies a customer data platform as one way to de-identify information before sending it to vendors that will not sign those agreements.

Federal enforcement has already shown the cost of mishandling health data. The Federal Trade Commission's BetterHelp order required the online counseling service to pay $7.8M and barred it from sharing sensitive health information for advertising after the agency alleged that BetterHelp disclosed data to advertising platforms despite privacy promises.

The legal picture is narrower than the broadest reading of the 2022 HHS bulletin. On June 20, 2024, a federal court vacated part of the guidance, rejecting the position that an IP address combined with a visit to certain unauthenticated public webpages automatically qualified as protected health information.

Healthcare organizations still face HIPAA duties when tracking technologies encounter actual protected information, particularly inside authenticated services, registration flows and appointment systems. FTC rules and a growing set of state privacy requirements add obligations beyond HIPAA. Ours Privacy is selling technical control amid that overlapping regulation, rather than relying on a single federal interpretation.

The founders are entering a populated market

Ours Privacy is competing with several approaches to the same data problem. Freshpaint offers healthcare-focused analytics infrastructure that blocks HIPAA identifiers before information reaches downstream tools. RudderStack sells a broader, warehouse-native customer data platform that supports HIPAA workloads and business associate agreements.

DeepIntent moved further into adjacent territory in March 2026 with Helix, a healthcare marketing cloud aimed largely at brands, agencies and pharmaceutical marketing workflows. Ours Privacy is making a more specific founder-led pitch: its platform was designed by marketers who had already tried operating a healthcare service without the measurement tools they needed.

The Series A gives Holton, Putterman and Zey capital to expand that internal workaround into enterprise infrastructure. Their advantage comes from having been the first customer. The next phase depends on whether Ours Privacy can make a wide product suite dependable enough for health systems that treat a leaking pixel as a legal, financial and patient-trust problem.